Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication

Cell Reports(2021)10.1016/j.celrep.2021.109479Source: DataRank Database

Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 120 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access120 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 5.39)OA: goldTopics (43)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Alexander S. Jureka ORCID,Jesus A. Silvas ORCID,Anthony M. Nicolini,Stacie Chvatal,Jared Carlson-Stevermer ORCID

Live enrichment

PubMed:34320401 OpenAlex:https://openalex.org/W3184615400

NIAID

Grant: P01AI120943

NIAID

Grant: R01AI125453

FWCI

5.39

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.celrep.2021.109479

publisherhttps://doi.org/10.1016/j.celrep.2021.109479

publisherhttps://api.elsevier.com/content/article/PII:S2211124721009062?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721009062?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34320401

Fields of Study

COVID-19 Clinical Research StudiesPeroxisome Proliferator-Activated ReceptorsLiver Disease Diagnosis and Treatment

MeSH Terms

COVID-19SARS-CoV-2AminopyridinesAnimalsAntiviral AgentsCell LineChlorocebus aethiopsHumansPyrimidinesRNA, ViralTriglyceridesVero CellsVirus ReplicationCaco-2 CellsLipid MetabolismLipoylationGene Knockout TechniquesClass III Phosphatidylinositol 3-KinasesFatty Acid Synthases

Keywords

Fatty acid synthasePalmitoylationViral replicationLipid metabolismCoronavirusBiologyFatty acidFatty acid metabolismFatty acid synthesisKinaseMetabolismReplication (statistics)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiochemistryCell biologyVirologyVirusEnzymeCoronavirus disease 2019 (COVID-19)MedicineInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being